SEARCH

SEARCH BY CITATION

References

  • 1
    National Institutes of Health Consensus Development Conference Statement: cervical cancer, April 1–3, 1996 National Institutes of Health Consensus Development Panel. J Natl Cancer Inst Monogr. vii-xix, 1996.
  • 2
    Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796802.
  • 3
    Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24 (Suppl. 3):S3/2634.
  • 4
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30(Suppl. 5):889.
  • 5
    Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials: International HPV screening working group. Lancet 2014;383:52432.
  • 6
    Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:816.
  • 7
    Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:17283.
  • 8
    Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990;71:17381.
  • 9
    Munoz M, Camargo M, Soto-De Leon SC, Rojas-Villarraga A, Sanchez R, Jaimes C, et al. The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods 2012;185:328.
  • 10
    Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:17319.
  • 11
    Lancuck L, Patnick J, Vessey M. A cohort effect in cervical screening coverage? J Med Screen 2008;15:279.
  • 12
    Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for Cervical cancer: a population-based study in Sweden. Prev Med 2001;32:48291.
  • 13
    Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004;13:34654.
  • 14
    NCIN. Profile of Cervical Cancer in England: Incidence, Mortality and Survival. National Cancer Intelligence Network (NCIN) publication. 2011 [www.ncin.org.uk]. Accessed 18 July 2013.
  • 15
    Lorenzi AT, Fregnani JH, Possati-Resende JC, Neto CS, Villa LL, Longatto-Filho A. Self-collection for high-risk HPV detection in Brazilian women using the careHPV test. Gynecol Oncol 2013;131:1314.
  • 16
    Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132:222336.
  • 17
    Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:5305.
  • 18
    Eperon I, Vassilakos P, Navarria I, Menoud PA, Gauthier A, Pache JC, et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing. BMC Cancer 2013;13:353.
  • 19
    Gök M, Heideman DA, van Kemenade FJ, de Vries AL, Berkhof J, Rozendaal L, et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012;48:1799808.
  • 20
    Gök M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. HPV testing on self-collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010;340:c1040.
  • 21
    Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial. Br J Cancer 2011;104:91520.